Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
20-23 May, 2025
Not Confirmed
Not Confirmed
21-23 May, 2025
Not Confirmed
Not Confirmed
21-23 May, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
20-23 May, 2025
Industry Trade Show
Not Confirmed
21-23 May, 2025
Industry Trade Show
Not Confirmed
21-23 May, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/us-drug-shortages-reduce-16-yoy-in-q1-2025-cns-drugs-antimicrobials-face-highest-scarcities
12 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/12/3078977/0/en/BioXcel-Therapeutics-Reports-First-Quarter-2025-Financial-Results-and-Provides-Business-Update.html
27 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/27/3050402/0/en/BioXcel-Therapeutics-Reports-Financial-Results-for-the-Fourth-Quarter-and-Full-Year-2024.html
11 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/11/3040398/0/en/BioXcel-Therapeutics-Strengthens-Cash-Position-to-Advance-SERENITY-At-Home-Pivotal-Phase-3-Safety-Trial-for-Acute-Treatment-of-Agitation-Associated-with-Bipolar-Disorders-or-Schizo.html
07 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/07/3038855/0/en/BioXcel-Therapeutics-Announces-33-Enrollment-in-SERENITY-At-Home-Pivotal-Phase-3-Safety-Trial-for-Acute-Treatment-of-Agitation-Associated-with-Bipolar-Disorders-or-Schizophrenia.html
04 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/04/3036978/0/en/BioXcel-Therapeutics-Announces-Closing-of-14-Million-Registered-Direct-Offering.html
03 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2025/03/03/3035455/0/en/BioXcel-Therapeutics-Announces-FDA-Closed-its-Inspection-of-Site-for-Phase-3-TRANQUILITY-II-Trial-for-Acute-Treatment-of-Agitation-Associated-with-Alzheimer-s-Dementia.html
ABOUT THIS PAGE